Publications by authors named "Susanne Sandgaard"

Claim this Profile
H
Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark.
Reimar W Thomsen, Lotte W B Christensen, Johnny Kahlert, Jakob S Knudsen, Anastasia Ustyugova, Susanne Sandgaard

Diabetes Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark.
Lars H Ehlers, Mark Lamotte, Mafalda C Ramos, Susanne Sandgaard, Pia Holmgaard

Diabetes Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark.
Lars H Ehlers, Mark Lamotte, Mafalda C Ramos, Susanne Sandgaard, Pia Holmgaard

J Comp Eff Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease.
Lars Holger Ehlers, Mark Lamotte, Sofia Monteiro, Susanne Sandgaard, Pia Holmgaard

Diabetes Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis